Top Insulin Resistance Supplements companies

The 5 key players our Insulin Resistance Supplements report profiles, and other companies free public records show in this market.

Key players in Insulin Resistance Supplements

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Insulin Resistance Supplements market
#CompanyWebsiteOur reports
1 Thorne — 198 reports
2 NOW Foods — 264 reports
3 Nature’s Bounty naturesbounty.com (opens in a new tab) 429 reports
4 Pure Encapsulations, LLC — 99 reports
5 Wholesome Story — 33 reports

Also active in Insulin Resistance Supplements

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Insulin Resistance Supplements, from free public records
CompanyWhere public records show them
Hangzhou Sciwind Biosciences Co., Ltd.
Signos

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in Insulin Resistance Supplements

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Hangzhou Sciwind Biosciences Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Signos 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Insulin Resistance Supplements reports by place

All 33 places for Insulin Resistance Supplements

Get the full Insulin Resistance Supplements report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.